These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15798561)

  • 21. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
    Bronckers IMGJ; Seyger MMB; West DP; Lara-Corrales I; Tollefson M; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Philipp S; Szalai Z; Vleugels RA; Holland K; Murphy R; Baselga E; Cordoro K; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Paller AS;
    JAMA Dermatol; 2017 Nov; 153(11):1147-1157. PubMed ID: 28903160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate for psoriasis.
    Boffa MJ; Chalmers RJ
    Clin Exp Dermatol; 1996 Nov; 21(6):399-408. PubMed ID: 9167333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.
    Yosipovitch G; Tang MB
    Drugs Aging; 2002; 19(11):847-63. PubMed ID: 12428994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pustular psoriasis.
    Farber EM; Nall L
    Cutis; 1993 Jan; 51(1):29-32. PubMed ID: 8419106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in Psoriasis.
    Smith J; Cline A; Feldman SR
    South Med J; 2017 Jan; 110(1):65-75. PubMed ID: 28052180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermacase. Psoriasis.
    Turchin I; Adams SP
    Can Fam Physician; 2006 Sep; 52(9):1073, 1080. PubMed ID: 17279215
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial.
    Kemeny L; Amaya M; Cetkovska P; Rajatanavin N; Lee WR; Szumski A; Marshall L; Mahgoub EY; Aldinç E
    BMC Dermatol; 2015 May; 15():9. PubMed ID: 25994179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The profile and outcome of pustular psoriasis in Singapore: a report of 28 cases.
    Tay YK; Tham SN
    Int J Dermatol; 1997 Apr; 36(4):266-71. PubMed ID: 9169323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological survey from 2009 to 2012 of psoriatic patients in Japanese Society for Psoriasis Research.
    Ito T; Takahashi H; Kawada A; Iizuka H; Nakagawa H;
    J Dermatol; 2018 Mar; 45(3):293-301. PubMed ID: 29115687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial experience with routine administration of etanercept in psoriasis.
    de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
    Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
    Sukarovska BG; Lipozencić J; Vrzogić P
    Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Evolving Landscape of Psoriasis Treatment.
    Armstrong AW; Gordon KB; Menter MA; Wu JJ
    Semin Cutan Med Surg; 2018 Feb; 37(2S):S39-S43. PubMed ID: 29614136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving outcomes in patients with psoriasis.
    Tidman MJ
    Practitioner; 2013 Jan; 257(1757):27-30, 3. PubMed ID: 23469725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Psoriasis: development and fatal complications].
    Roth PE; Grosshans E; Bergoend H
    Ann Dermatol Venereol; 1991; 118(2):97-105. PubMed ID: 2048897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety profiles and efficacy of infliximab therapy in Japanese patients with plaque psoriasis with or without psoriatic arthritis, pustular psoriasis or psoriatic erythroderma: Results from the prospective post-marketing surveillance.
    Torii H; Terui T; Matsukawa M; Takesaki K; Ohtsuki M; Nakagawa H;
    J Dermatol; 2016 Jul; 43(7):767-78. PubMed ID: 26704926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of vitamin D analog use for the treatment of psoriasis.
    Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
    J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial).
    Strohal R; Puig L; Chouela E; Tsai TF; Melin J; Freundlich B; Molta CT; Fuiman J; Pedersen R; Robertson D
    J Dermatolog Treat; 2013 Jun; 24(3):169-78. PubMed ID: 22251226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Palmoplantar pustular psoriasis following initiation of a beta-blocker: disease control with low-dose methotrexate.
    Stanford CW; Kollipara R; Melookaran AM; Hall JC
    Cutis; 2014 Sep; 94(3):153-5. PubMed ID: 25279477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric psoriasis.
    Busch AL; Landau JM; Moody MN; Goldberg LH
    Skin Therapy Lett; 2012 Jan; 17(1):5-7. PubMed ID: 22358228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.